The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The discovery of enzyme targeting inhibitors is a popular area of drug research.
📊
Key Findings & Data:Biological activities of the compounds bearing phenol and heteroaryl groups make them popular groups in drug design targeting important enzymes such as acetylcholinesterase (AChE, E.C.3.1.1.7) and carbonic anhydrases (CAs, EC 4.2.1.1). 1-(4-hydroxyphenyl)-2-((aryl)thio)ethanones as possible AChE and CAs inhibitors were synthesized, and their chemical structures were confirmed by IR, H-1 NMR, C-13 NMR, and HRMS.
💡
Conclusion & Impact:The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
The discovery of enzyme targeting inhibitors is a popular area of drug research. Biological activities of the compounds bearing phenol and heteroaryl groups make them popular groups in drug design targeting important enzymes such as acetylcholinesterase (AChE, E.C.3.1.1.7) and carbonic anhydrases (CAs, EC 4.2.1.1). 1-(4-hydroxyphenyl)-2-((aryl)thio)ethanones as possible AChE and CAs inhibitors were synthesized, and their chemical structures were confirmed by IR, H-1 NMR, C-13 NMR, and HRMS. The compounds 2 and 4 were found potent AChE inhibitors with the Ki values of 22.13 +/- 1.96 nM and 23.71 +/- 2.95 nM, respectively, while the compounds 2 (Ki = 8.61 +/- 0.90 nM, on hCA I) and 1 (Ki = 8.76 +/- 0.84 nM, on hCA II) had considerable CAs inhibitory potency. The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
YAMALİ, C., GUL, H. I., DEMİR, Y., KAZAZ, C., GULCİN, I. (2020). Synthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl)thio)ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitors. Turkish Journal of Chemistry, Cilt: 44 - Sayı: 4, 1058–1067. https://ajindex.com/articles/214927
Akincioglu A, 2015, BIOORGAN MED CHEM, V23, P3592, DOI 10.1016/j.bmc.2015.04.019 Akincioglu A, 2013, BIOORGAN MED CHEM, V21, P1379, DOI 10.1016/j.bmc.2013.01.019 Aksu K, 2013, BIOORGAN MED CHEM, V21, P2925, DOI 10.1016/j.bmc.2013.03.077 Alterio V, 2012, CHEM REV, V112, P4421, DOI 10.1021/cr200176r Arabaci B, 2014,
MOLECULES, V19, P10103, DOI 10.3390/molecules190710103 Boztas M, 2015, J MED CHEM, V58, P640, DOI 10.1021/jm501573b BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3 Bytyqi-Damoni A, 2020, J MOL STRUCT, V1202, DOI 10.1016/j.molstruc.2019.127297 Cakmak KC, 2019, TOXICOL REP, V6, P1273, DOI 10.1016/j.toxrep.2019.11.003 Cevik UA, 2019,
MOLECULES, V24, DOI 10.3390/molecules24050861 Chaves S, 2020,
MOLECULES, V25, DOI 10.3390/molecules25040985 El-Sayed NA, 2019, BIOORG CHEM, V93, DOI 10.1016/j.bioorg.2019.103312 ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9 Gulcin I, 2013, MINI-REV MED CHEM, V13, P408 Guney M, 2014, BIOORGAN MED CHEM, V22, P3537, DOI 10.1016/j.bmc.2014.04.007 Innocenti A, 2010, BIOORG MED CHEM LETT, V20, P5050, DOI 10.1016/j.bmcl.2010.07.038 Ivanova L, 2020,
MOLECULES, V25, DOI 10.3390/molecules25081846 Kocyigit UM, 2017, BIOORG CHEM, V70, P118, DOI 10.1016/j.bioorg.2016.12.001 Li GL, 2018, EUR J MED CHEM, V148, P238, DOI 10.1016/j.ejmech.2018.01.028 Li JC, 2016, BIOORG MED CHEM LETT, V26, P3881, DOI 10.1016/j.bmcl.2016.07.017 Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036 Mehr-un-Nisa, 2015, BIOORGAN MED CHEM, V23, P6014, DOI 10.1016/j.bmc.2015.06.051 Ozgeris B, 2016, BIOORGAN MED CHEM, V24, P2318, DOI 10.1016/j.bmc.2016.04.002 Ozgun DO, 2019, BIOORG CHEM, V84, P511, DOI 10.1016/j.bioorg.2018.12.028 Ozgun DO, 2016, J ENZYM INHIB MED CH, V31, P1498, DOI 10.3109/14756366.2016.1149479 Pradaux-Caggiano F, 2012,
MEDCHEMCOMM, V3, P1117, DOI 10.1039/c2md20091k Reddy MVR, 2010, BIOORGAN MED CHEM, V18, P2317, DOI 10.1016/j.bmc.2010.01.051 Sang ZP, 2017, BIOORG MED CHEM LETT, V27, P5046, DOI 10.1016/j.bmcl.2017.09.057 Sarikaya SBO, 2011, BIOORG MED CHEM LETT, V21, P4259, DOI 10.1016/j.bmcl.2011.05.071 Scozzafava A, 2015, J ENZYM INHIB MED CH, V30, P586, DOI 10.3109/14756366.2014.956310 Senturk M, 2009, BIOORGAN MED CHEM, V17, P3207, DOI 10.1016/j.bmc.2009.01.067 Stasiuk M, 2008, FOOD CHEM, V108, P996, DOI 10.1016/j.foodchem.2007.12.011 Sujayev A, 2020, APPL ORGANOMET CHEM, V34, DOI 10.1002/aoc.5329 Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2